Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect. [electronic resource]
- British journal of haematology Jul 2002
- 239-42 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1046/j.1365-2141.2002.03549.x doi
Aged Bone Remodeling--drug effects Diphosphonates--therapeutic use Disease Progression Female Follow-Up Studies Humans Infusions, Intravenous Male Middle Aged Multiple Myeloma--drug therapy Pamidronate Treatment Failure